Frontal white matter abnormalities following chronic ketamine use: A diffusion tensor imaging study

Brain

Volumn 133, Issue 7, 2010, Pages 2115-2122

  Liao, Yanhui ^a   Tang, Jinsong ^a   Ma, Mingdong ^b   Wu, Zhimei ^c   Yang, Mei ^c   Wang, Xuyi ^a   Liu, Tieqiao ^a   Chen, Xiaogang ^a   Fletcher, Paul C ^d   Hao, Wei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Kangda Voluntary Drug Rehabilitation Centre   (China)

^c Hunan Brain Hospital   (China)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

diffusion tensor imaging; fractional anisotropy; frontal white matter; ketamine dependence; voxel based morphometry

Indexed keywords

KETAMINE;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DRUG DEPENDENCE; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL CORTEX; HUMAN; IN VIVO STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; WHITE MATTER;

ADULT; DIFFUSION TENSOR IMAGING; FEMALE; FRONTAL LOBE; HUMANS; KETAMINE; MALE; NERVE FIBERS, MYELINATED; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77954369562     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq131     Document Type: Article

References (51)

1. Aan Het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 2010; 67: 139-145
2. Ahmed SN, Petchkovsky L. Abuse of ketamine. Br J Psychiatry 1980; 137: 303.
3. Alicata D, Chang L, Cloak C, Abe K, Ernst T. Higher diffusion in striatum and lower fractional anisotropyin white matter of methamphetamine users. Psychiatry Res 2009; 174: 1-8.
4. Amann LC, Halene TB, Ehrlichman RS, Luminais SN, Ma N, Abel T, et al. Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials. Neurobiol Dis 2009; 35: 311-317
5. Arnone D, Barrick TR, Chengappa S, Mackay CE, Clark CA, bou-Saleh MT. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. Neuroimage 2008; 41: 1067-1074
6. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed 2002; 15: 435-455
7. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289-300.
8. bi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 2002; 22: 3708-3719
9. Camchong J, Lim KO, Sponheim SR, Macdonald AW. Frontal white matter integrity as an endophenotype for schizophrenia: diffusion tensor imaging in monozygotic twins and patients' nonpsychotic relatives. Front Hum Neurosci 2009; 3: 35.
10. Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW, Man CW, et al. 'Street ketamine'-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 2007; 13: 311-313
11. Chung A, Lyoo IK, Kim SJ, Hwang J, Bae SC, Sung YH, et al. Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol 2007; 10: 765-775
12. Domino EF, Chodeff P, Corssen G. Pharmacologic effects of Ci-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther 1965; 6: 279-291
13. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Brain Res Rev 1995; 20: 250-267
14. Fang YX, Wang YB, Shi J, Liu ZM, Lu L. Recent trends in drug abuse in China. Acta Pharmacol Sin 2006; 27: 140-144
15. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-878
16. Gill JR, Stajic M. Ketamine in non-hospital and hospital deaths in New York City. J Forensic Sci 2000; 45: 655-658
17. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobio-logical basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-1652
18. Hess CP. Update on diffusion tensor imaging in Alzheimer's disease. Magn Reson Imaging Clin N Am 2009; 17: 215-224
19. Jansen KL. Ketamine-can chronic use impair memory? Int J Addict 1990; 25: 133-139
20. Jeong B, Wible CG, Hashimoto R, Kubicki M. Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia. Hum Brain Mapp 2009; 30: 4138-4151
21. Joe-Laidler K, Hunt G. Sit Down to Float: The Cultural Meaning of Ketamine Use in Hong Kong. Addict Res Theory 2008; 16: 259-271
22. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199-214.
23. Krystal JH, Perry EB Jr, Gueorguieva R, Belger A, Madonick SH, bi-Dargham A, et al. Comparative and interactive human psychopharma-cologic effects of ketamine and amphetamine: implications for gluta-matergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 2005; 62: 985-994
24. Kyriakopoulos M, Bargiotas T, Barker GJ, Frangou S. Diffusion tensor imaging in schizophrenia. Eur Psychiatry 2008; 23: 255-273
25. Kyriakopoulos M, Frangou S. Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr Opin Psychiatry 2009; 22: 168-176
26. Le BD, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001; 13: 534-546
27. Leung KS, Li JH, Tsay WI, Callahan C, Liu SF, Hsu J, et al. Dinosaur girls, candy girls, and Trinity: voices of Taiwanese club drug users. J Ethn Subst Abuse 2008; 7: 237-257
28. Liu H, Li L, Hao Y, Cao D, Xu L, Rohrbaugh R, et al. Disrupted white matter integrity in heroin dependence: a controlled study utilizing diffusion tensor imaging. Am J Drug Alcohol Abuse 2008; 34: 562-575
29. Lua AC, Lin HR, Tseng YT, Hu AR, Yeh PC. Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse. Forensic Sci Int 2003; 136: 47-51.
30. Maxwell CR, Ehrlichman RS, Liang Y, Trief D, Kanes SJ, Karp J, et al. Ketamine produces lasting disruptions in encoding of sensory stimuli. J Pharmacol Exp Ther 2006; 316: 315-324
31. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 1998; 352: 1433-1437
32. Moeller FG, Hasan KM, Steinberg JL, Kramer LA, Dougherty DM, Santos RM, et al. Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology 2005; 30: 610-617
33. Morgan CJ, Huddy V, Lipton M, Curran HV, Joyce EM. Is persistent ketamine use a valid model of the cognitive and oculomotor deficits in schizophrenia? Biol Psychiatry 2009; 65: 1099-1102
34. Morgan CJ, Monaghan L, Curran HV. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of keta-mine in recreational users who have substantially reduced their use of the drug. Addiction 2004; 99: 1450-1461
35. Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic keta-mine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010; 105: 121-133
36. Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, et al. Altered prefrontal dopaminergic function in chronic recreational keta-mine users. Am J Psychiatry 2005; 162: 2352-2359
37. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci 2005; 8: 1445-1449.
38. Petrakis IL, Limoncelli D, Gueorguieva R, Jatlow P, Boutros NN, Trevisan L, et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry 2004; 161: 1776-1782
39. Pfefferbaum A, Rosenbloom M, Rohlfing T, Sullivan EV. Degradation of association and projection white matter systems in alcoholism detected with quantitative fiber tracking. Biol Psychiatry 2009; 65: 680-690
40. Pomarol-Clotet E, Canales-Rodriguez EJ, Salvador R, Sarro S, Gomar JJ, Vila F, et al. Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging. Mol Psychiatry 2010, Advance Access published on January 12, 2010, doi:10.1038/mp.2009.146.
41. Rosenbloom M, Sullivan EV, Pfefferbaum A. Using magnetic resonance imaging and diffusion tensor imaging to assess brain damage in alcoholics. Alcohol Res Health 2003; 27: 146-152
42. Salo R, Nordahl TE, Buonocore MH, Natsuaki Y, Waters C, Moore CD, et al. Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study. Biol Psychiatry 2009; 65: 122-128
43. Schifano F, Corkery J, Oyefeso A, Tonia T, Ghodse AH. Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006). J Clin Psychopharmacol 2008; 28: 114-116
44. Scholz J, Klein MC, Behrens TE, Johansen-Berg H. Training induces changes in white-matter architecture. Nat Neurosci 2009; 12: 1370-1371
45. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 1992; 49: 624-629
46. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028-6036
47. Tsai TH, Cha TL, Lin CM, Tsao CW, Tang SH, Chuang FP, et al. Ketamine-associated bladder dysfunction. Int J Urol 2009; 16: 826-829
48. Tsukada H, Nishiyama S, Fukumoto D, Sato K, Kakiuchi T, Domino EF. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys. Neuropsychopharmacology 2005; 30: 1861-1869
49. Vollenweider FX, Geyer MA. A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull 2001; 56: 495-507.
50. Wang JJ, Durazzo TC, Gazdzinski S, Yeh PH, Mon A, Meyerhoff DJ. MRSI and DTI: a multimodal approach for improved detection of white matter abnormalities in alcohol and nicotine dependence. NMR Biomed 2009; 22: 516-522
51. Wolff K, Winstock AR. Ketamine: from medicine to misuse. CNS Drugs 2006; 20: 199-218.